Brian Casey[email protected]MRIMedradMedrad, the Indianola, PA, developer of contrast injection technology, will feature the next generation of its Continuum MR-compatible infusion devices, originally introduced in 2002.November 9, 2005MRIMednovusMednovus will exhibit its line of ferromagnetic detection systems that enhance patient safety by alerting healthcare providers to metal objects on patients before they enter the MRI magnet.November 9, 2005MRIIRadimedThe Winter Park, FL, company will display its MRidium infusion system, which includes the 3850 MRidium MRI infusion pump, as well as a pair of new products.November 9, 2005MRIHologicHologic has traditionally focused on women's imaging, but the Bedford, MA, company will be touting its entry into the U.S. MRI market, thanks to a new relationship with Italian medical imaging developer Esaote.November 9, 2005MRIHitachi Medical Systems AmericaA brand-new 1.5-tesla superconducting scanner will take the spotlight in the MRI section of Hitachi's booth at McCormick Place. The Twinsburg, OH, company will also show enhancements and upgrades for its 0.3-tesla and 0.7-tesla magnets.November 9, 2005MRIGE HealthcareGE will add three new scanners to its Signa HD product family: two 1.5-tesla models and a 3-tesla product.November 9, 2005MRIBruker BioSpinClinScan, a new 7-tesla scanner for research applications, will be featured in Bruker's RSNA booth.November 9, 2005MRIAurora Imaging TechnologyThis developer of breast MRI scanners will shine the spotlight on advancements to its Aurora 1.5-tesla dedicated breast MRI system.November 9, 2005Digital X-RayAgfa HealthCareThis Ridgefield Park, NJ, company will use the RSNA show to launch a new computed radiography system that incorporates several new technologies in storage phosphor-based image acquisition.November 7, 2005Musculoskeletal RadiologyMRI equivocal for conservative back pain managementNovember 7, 2005Previous PagePage 135 of 190Next PageTop StoriesAIU.S. FDA may need to clarify SaMD validation standardsIn a video interview, a Dana-Farber Cancer Institute expert describes what the "rigor spectrum" is in validation study designs.Molecular ImagingPSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancerWomens ImagingPreop breast MRI improves surgical planning, but use disparities remainWomens ImagingFIGO classification from MRI leads to moderate agreement among radsSponsor ContentRegister Now: Breaking Barriers in Breast Imaging Webinar